A multicenter, randomized, open-label comparison of the safety and efficacy of tigecycline with that of ampicillin-sulbactam or amoxicillin-clavulanate to treat complicated skin and skin structure infections

Trial Profile

A multicenter, randomized, open-label comparison of the safety and efficacy of tigecycline with that of ampicillin-sulbactam or amoxicillin-clavulanate to treat complicated skin and skin structure infections

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 May 2016

At a glance

  • Drugs Tigecycline (Primary) ; Amoxicillin/clavulanic acid; Sulbactam/ampicillin
  • Indications Bacterial infections; Skin and soft tissue infections
  • Focus Therapeutic Use
  • Sponsors Wyeth
  • Most Recent Events

    • 08 Aug 2012 Trial phase changed from III to IV as reported by ClinicalTrials.gov.
    • 28 Jun 2012 Additional trial locations added as reported by European Clinical Trials Database.
    • 10 Apr 2010 Results presented at the 20th European Congress of Clinical Microbiology and Infectious Diseases.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top